Author: Dr. David Lowemann

Facebook Live: Confronting Opioid Addiction

Three medications have been approved by the Food and Drug Administration to treat opioid addiction: methadone, buprenorphine and naltrexone. But access to them depends largely on where you live. Methadone and buprenorphine are the two most popular options. But many California communities, particularly rural ones, have neither a methadone clinic nor a doctor who can […]

Published on April 26, 2018

Deep Learning Methods to Process fMRI Data and Their Application in the Diagnosis of Cognitive Impairment: A Brief Overview and Our Opinion

Dong Wen, Zhenhao Wei, Yanhong Zhou, Guolin Li, Xu Zhang, Wei Han Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in […]

Published on April 26, 2018

Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies

Paula Garcia-Esparcia, Daniela Diaz-Lucena, Marina Ainciburu, Benjamin Torrejón-Escribano, Margarita Carmona, Franc Llorens, Isidro Ferrer Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen […]

Published on April 26, 2018